Literature DB >> 9399956

Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.

S M Monte1, K Ghanbari, W H Frey, I Beheshti, P Averback, S L Hauser, H A Ghanbari, J R Wands.   

Abstract

We have isolated a novel Alu sequence-containing cDNA, designated AD7c-NTP, that is expressed in neurons, and overexpressed in brains with Alzheimer's disease (AD). The 1,442-nucleotide AD7c-NTP cDNA encodes an approximately 41-kD protein. Expression of AD7c-NTP was confirmed by nucleic acid sequencing of reverse transcriptase PCR products isolated from brain. AD7c-NTP cDNA probes hybridized with 1. 4 kB mRNA transcripts by Northern blot analysis, and monoclonal antibodies generated with the recombinant protein were immunoreactive with approximately 41-45-kD and approximately 18-21-kD molecules by Western blot analysis. In situ hybridization and immunostaining studies localized AD7c-NTP gene expression in neurons. Using a quantitative enzyme-linked sandwich immunoassay (Ghanbari, K., I. Beheshti, and H. Ghanbari, manuscript submitted for publication) constructed with antibodies to the recombinant protein, AD7c-NTP levels were measured under code in 323 clinical and postmortem cerebrospinal fluid (CSF) samples from AD, age-matched control, Parkinson's disease, and neurological disease control patients. The molecular mass of the AD7c-NTP detected in CSF was approximately 41 kD. In postmortem CSF, the mean concentration of AD7c-NTP in cases of definite AD (9.2+/-8.2 ng/ml) was higher than in the aged control group (1.6+/-0.9; P < 0.0001). In CSF samples from individuals with early possible or probable AD, the mean concentration of AD7c-NTP (4.6+/-3.4) was also elevated relative to the levels in CSF from age-matched (1.2+/-0.7) and neurological disease (1.0+/-0.9) controls, and ambulatory patients with Parkinson's disease (1.8+/-1.1) (all P < 0.001). CSF levels of AD7c-NTP were correlated with Blessed dementia scale scores (r = 0. 66; P = 0.0001) rather than age (r = -0.06; P > 0.1). In vitro studies demonstrated that overexpression of AD7c-NTP in transfected neuronal cells promotes neuritic sprouting and cell death, the two principal neuroanatomical lesions correlated with dementia in AD. The results suggest that abnormal AD7c-NTP expression is associated with AD neurodegeneration, and during the early stages of disease, CSF levels correlate with the severity of dementia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399956      PMCID: PMC508522          DOI: 10.1172/JCI119864

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

3.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

4.  The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice.

Authors:  F M LaFerla; B T Tinkle; C J Bieberich; C C Haudenschild; G Jay
Journal:  Nat Genet       Date:  1995-01       Impact factor: 38.330

5.  Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease.

Authors:  K Chandrasekaran; T Giordano; D R Brady; J Stoll; L J Martin; S I Rapoport
Journal:  Brain Res Mol Brain Res       Date:  1994-07

6.  Neuronal and glial gene expression in neocortex of Down's syndrome and Alzheimer's disease.

Authors:  K L Goodison; I M Parhad; C L White; A A Sima; A W Clark
Journal:  J Neuropathol Exp Neurol       Date:  1993-05       Impact factor: 3.685

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system.

Authors:  A M Cataldo; J L Barnett; S A Berman; J Li; S Quarless; S Bursztajn; C Lippa; R A Nixon
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

9.  Immunohistochemical evidence for apoptosis in Alzheimer's disease.

Authors:  J H Su; A J Anderson; B J Cummings; C W Cotman
Journal:  Neuroreport       Date:  1994-12-20       Impact factor: 1.837

10.  Homologous recombination among three intragene Alu sequences causes an inversion-deletion resulting in the hereditary bleeding disorder Glanzmann thrombasthenia.

Authors:  L Li; P F Bray
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

View more
  22 in total

Review 1.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 2.  Cerebrospinal fluid protein biomarkers for Alzheimer's disease.

Authors:  Kaj Blennow
Journal:  NeuroRx       Date:  2004-04

Review 3.  Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.

Authors:  Anders Lönneborg
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  A sandwich enzyme immunoassay for measuring AD7C-NTP as an Alzheimer's disease marker: AD7C test.

Authors:  K Ghanbari; H A Ghanbari
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

5.  Development of a Novel Urine Alzheimer-Associated Neuronal Thread Protein ELISA Kit and Its Potential Use in the Diagnosis of Alzheimer's Disease.

Authors:  Lina Ma; Rong Wang; Ying Han; Shuli Sheng; Jianan Zhu; Zhijuan Ji; Zhiwei Zhao; Ziqing Cao; Peichang Wang
Journal:  J Clin Lab Anal       Date:  2015-06-03       Impact factor: 2.352

6.  Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease.

Authors:  Susanna Levy; Matthew McConville; Glorie A Lazaro; Paul Averback
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 7.  The transcript repeat element: the human Alu sequence as a component of gene networks influencing cancer.

Authors:  Paula Moolhuijzen; Jerzy K Kulski; David S Dunn; David Schibeci; Roberto Barrero; Takashi Gojobori; Matthew Bellgard
Journal:  Funct Integr Genomics       Date:  2010-08       Impact factor: 3.410

8.  Chronic ethanol diet increases regulatory T-cell activity and inhibits hepatitis C virus core-specific cellular immune responses in mice.

Authors:  Vivian Ortiz; Jack R Wands
Journal:  Hepatol Res       Date:  2013-07-04       Impact factor: 4.288

Review 9.  Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Authors:  Christopher D Aluise; Renã A Sowell; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2008-08-07

Review 10.  The persistent contributions of RNA to eukaryotic gen(om)e architecture and cellular function.

Authors:  Jürgen Brosius
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-07-31       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.